Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
Q1 2023 vs. Q4 2022
How the institutions holding Terns Pharmaceuticals, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 65 | 79 | +14 |
| Shares | 49.7M | 53.2M | +3.49M (+7.0%) |
| Value | $506.2M | $630.2M | +$124.0M (+24.5%) |
New holders (27)
Institutions that held Terns Pharmaceuticals, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
Sold out (13)
Institutions that held Terns Pharmaceuticals, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| RTW Investments, LP | 1,000,000 | $10.2M |
| Pura Vida Investments, LLC | 605,079 | $6.16M |
| Armistice Capital, LLC | 560,000 | $5.70M |
| Bank of Montreal | 194,100 | $1.98M |
| Endurant Capital Management LP | 135,994 | $1.38M |
| Monashee Investment Management LLC | 122,500 | $1.25M |
| Walleye Capital LLC | 73,611 | $749.4K |
| Altium Capital Management LP | 70,000 | $712.6K |
| HRT Financial LP | 35,090 | $357.0K |
| Acadian Asset Management LLC | 22,599 | $229.0K |
| Caas Capital Management LP | 20,000 | $203.6K |
| Dynamic Technology Lab Private Ltd | 15,709 | $160.0K |
| Raymond James & Associates | 12,488 | $127.1K |